These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 35328843)

  • 1. Post-Discharge
    Jachowicz E; Pac A; Różańska A; Gryglewska B; Wojkowska-Mach J
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328843
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, epidemiology and control of
    Singhal T; Shah S; Tejam R; Thakkar P
    Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
    Spigaglia P
    Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems of
    Kiersnowska Z; Lemiech-Mirowska E; Ginter-Kramarczyk D; Kruszelnicka I; Michałkiewicz M; Marczak M
    Ann Agric Environ Med; 2021 Jun; 28(2):224-230. PubMed ID: 34184502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare-associated
    Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
    Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
    Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
    Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Antibiotic Consumption and Incidence of
    Kim B; Kim J; Pai H
    J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority.
    Roncarati G; Dallolio L; Leoni E; Panico M; Zanni A; Farruggia P
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28075419
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
    Yu H; Flaster N; Casanello AL; Curcio D
    Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
    Johnson SW; Brown SV; Priest DH
    Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.
    Murphy CR; Avery TR; Dubberke ER; Huang SS
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):20-8. PubMed ID: 22173518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal change of risk factors in hospital-acquired
    Song J; Cohen B; Zachariah P; Liu J; Larson EL
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1048-1057. PubMed ID: 32468975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.